GE HealthCare Launches Secondary Offering of 13.3 Million Shares
GE HealthCare Technologies Inc. (Nasdaq: GEHC) announced today the launch of a secondary underwritten public offering of 13,281,302 shares of its common stock (the “GEHC Shares”). The company is not…
BioIVT and KRISHGEN BioSystems Announce Exclusive South Asia Agreement
BioIVT, a global leader in biospecimen solutions and research support for drug and diagnostic development, has announced an exclusive partnership with KRISHGEN BioSystems. KRISHGEN, a prominent provider of life science…
SBC Medical Group and MEDIROM Group Form Business Partnership
SBC Medical Group Holdings (California, USA, CEO: Aikawa Yoshiyuki), a provider of management support to medical institutions globally, has entered into a business partnership with MEDIROM Corporation (Headquarters: Minato-ku, Tokyo,…
Guardant Health Reports Q3 2024 Results and Raises Revenue Guidance
Key Financial Highlights for Q3 2024: Recent Operating Highlights: CEO Comments: “We had another record quarter, driven by significant reimbursement tailwinds for Guardant360 and strong volume growth,” said Helmy Eltoukhy,…
NovaBay Accepts Revised Offer from PRN and Increases Asset Purchase Price
NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) (“NovaBay”) announced today that it has accepted a revised offer from PRN Physician Recommended Nutriceuticals, LLC (“PRN”) to raise the base purchase price for…
Minds + Assembly Expands Healthcare Platform by Partnering with BOLDSCIENCE
Minds + Assembly has announced its strategic partnership with BOLDSCIENCE, a full-service medical communications agency, to expand its world-class healthcare communications and commercialization platform. The collaboration will enhance Minds +…
Burjeel Holdings and Response Plus Launch $1M Human Energy Health Award
Burjeel Holdings and Response Plus Launch $1 Million Human Energy Health Award at ADIPEC 2024Burjeel Holdings, a leading super-specialty healthcare provider in the MENA region, and Response Plus Medical Services…
Inocras and Summit Pharma Partner to Transform Clinical Genomics in Japan
Inocras Inc. (San Diego, CA; President & CEO: Jehee Suh) and Summit Pharmaceuticals International Corporation (Tokyo, Japan; President & CEO: Katsuya Okuyama) have signed a Memorandum of Understanding (MOU) to…
Endologix Presents 36-Month DETOUR2 Study Results at 2024 VIVA
Endologix LLC, a global leader in medical devices for vascular disease, today revealed the final 36-month results of its DETOUR2 Study. The DETOUR System provides an innovative solution for treating…
Fusion Orthopedics Wins USPTO Judgment Against Extremity Medical
Fusion Orthopedics, LLC has secured a major victory against Extremity Medical, LLC following a ruling by the U.S. Patent and Trademark Office’s Patent Trial and Appeal Board (PTAB). The PTAB…
MaaT Pharma Reports Q3 2024 Results, Business Update & Management Changes
MaaT Pharma (EURONEXT: MAAT), a clinical-stage biotech leader in developing microbiome-based therapies for cancer, today provided an update on its activities and financial performance for the third quarter of 2024,…
e4shield™: New Frontline Weapon Against Viruses at MEDICA
e4life, a joint venture formed by two global leaders—ELT Group, a world leader in electronic defense, and Lendlease, experts in large-scale urban regeneration—will present its e4shield™ technology at MEDICA 2024.…